Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation

Journal of Virology

Volumn 75, Issue 13, 2001, Pages 6228-6234

  Swenson, J J ^a   Holley Guthrie, E ^a   Kenney, S C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMEDIATE EARLY PROTEIN; PROTEIN BRLF 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS REPLICATION;

CREB-BINDING PROTEIN; DNA-BINDING PROTEINS; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 0034979367     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.13.6228-6234.2001     Document Type: Article

References (53)

1. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing levels of phosphorylated p38 and c-Jun N-terminal kinases
2. The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein
3. Rescue of the Epstein-Barr virus BZLF1 mutant Z(S186A) early gene activation defect by the BRLF1 gene product
4. A family of transcriptional adaptor proteins targeted by E1A oncoprotein
5. CBP-induced stimulation of c-fos activity is abrogated by E1A
6. The CBP co-activator is a histone acetyltransferase
7. Stimulation of c-jun activity by CBP: c-jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro
8. Cooperation of Stat2 and p300/CBP in signaling induced by interferon-alpha
9. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter
10. Phosphorylated CREB binds specifically to the nuclear protein CBP
11. Activation of expression of latent Epstein-Barr virus after gene transfer with a small cloned fragment of heterogeneous viral DNA
12. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators
13. CBP as a transcriptional coactivator of c-myb
14. The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300
15. Association of p300 and CBP with simian virus 40 large T antigen
16. The Epstein-Barr virus lytic program is controlled by the cooperative functions of two transactivators
17. Specificity of cyclin E-cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator
18. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities
19. CREB-binding protein/p300 are transcriptional coactivators of p65
20. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
21. Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R
22. Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter
23. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters
24. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen
25. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16
26. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner
27. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein
28. Histone acetylation and reactivation of Epstein-Barr virus from latency
29. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
30. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators
31. Epstein-Barr virus and its replication
32. A positive role for histone acetylation in transcription factor access to nucleosomal DNA
33. Adenovirus E1A downregulates c-jun- and junB-mediated transcription by targeting the coactivator p300
34. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome
35. p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen
36. Domains of the Epstein-Barr virus (EBV) transcription factor R are required for dimerization, DNA binding and activation
37. Histone acetylation reduces nucleosome core particle linking number change
38. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1
39. The Epstein-Barr virus Rta protein activates lyric cycle genes and can disrupt latency in B lymphocytes
40. The role of the Epstein-Barr virus Rta protein in activation of distinct classes of viral lytic cycle genes
41. Epstein-Barr virus
42. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle
43. CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter
44. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein
45. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region
46. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction
47. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment
48. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes
49. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro
50. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo
51. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism
52. The Epstein-Barr virus immediate-early promoter, BRLF1, can be activated by the cellular Sp1 transcription factor
53. The amino-terminal C/H1 domain of CREB binding protein mediates Zta transcriptional activation of latent Epstein-Barr virus